Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Mar 2, 2016

29777_dirs_2016-03-02_7f20999b-e695-4d39-9072-85c9fa638141.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-02-29

Reporting Person: WHITE MILES D (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-29 Common shares without par value F 70354 $39.52 Disposed 1460517 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 29526 Indirect
Common shares without par value 8818 Indirect
Common shares without par value 8832 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 29, 2016.

F2: The reporting person disclaims beneficial ownership of all securities held by his son.